Investigation of the risk factors in the development of radionecrosis in patients with brain metastases undergoing stereotactic radiotherapy.

IF 1.8 4区 医学 Q3 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING British Journal of Radiology Pub Date : 2024-05-07 DOI:10.1093/bjr/tqae051
Bedriye Doğan, Harun Demir, Naciye Işık, Gun Gunalp, Hediye Pınar Günbey, Gökhan Yaprak
{"title":"Investigation of the risk factors in the development of radionecrosis in patients with brain metastases undergoing stereotactic radiotherapy.","authors":"Bedriye Doğan, Harun Demir, Naciye Işık, Gun Gunalp, Hediye Pınar Günbey, Gökhan Yaprak","doi":"10.1093/bjr/tqae051","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>To investigate the incidence, timing, and the factors predictors radionecrosis (RN) development in brain metastases (BMs) undergoing stereotactic radiotherapy (SRT).</p><p><strong>Methods: </strong>The study evaluated 245 BMs who exclusively received SRT between 2010 and 2020. RN was detected pathologically or radiologically.</p><p><strong>Results: </strong>The median of follow-up was 22.6 months. RN was detected in 18.4% of the metastatic lesions, and 3.3% symptomatic, 15.1% asymptomatic. The median time of RN was 22.8 months (2.5-39.5), and the rates at 6, 12, and 24 months were 16.8%, 41.4%, and 66%, respectively. Univariate analysis revealed that Graded Prognostic Assessment (P = .005), Score Index of Radiosurgery (P = .015), Recursive Partitioning Analysis (P = .011), the presence of primary cancer (P = .004), and localization (P = .048) significantly increased the incidence of RN. No significant relationship between RN and brain-gross tumour volume doses, planning target volume, fractionation, dose (P > .05). Multivariate analysis identified SIR > 6 (OR: 1.30, P = .021), primary of breast tumour (OR: 2.33, P = .031) and supratentorial localization (OR: 3.64, P = .025) as risk factors.</p><p><strong>Conclusions: </strong>SRT is used effectively in BMs. The incidence of RN following SRT is undeniably frequent. It was observed that the incidence rate increased as the follow-up period increased. We showed that brain-GTV doses are not predictive of RN development, unlike other publications. In study, a high SIR score and supratentorial localization were identified as factors that increased the risk of RN.</p><p><strong>Advances in knowledge: </strong>RN is still a common complication after SRT. Symptomatic RN is a significant cause of morbidity. The causes of RN are still not clearly identified. In many publications, brain dose and volumes have been found to be effective in RN. But, with this study, we found that brain dose volumes and fractionation did not increase the incidence of RN when brain doses were taken into account. The most important factor in the development of RN was found to be related to long survival after SRT.</p>","PeriodicalId":9306,"journal":{"name":"British Journal of Radiology","volume":null,"pages":null},"PeriodicalIF":1.8000,"publicationDate":"2024-05-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11075992/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"British Journal of Radiology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1093/bjr/tqae051","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING","Score":null,"Total":0}
引用次数: 0

Abstract

Objective: To investigate the incidence, timing, and the factors predictors radionecrosis (RN) development in brain metastases (BMs) undergoing stereotactic radiotherapy (SRT).

Methods: The study evaluated 245 BMs who exclusively received SRT between 2010 and 2020. RN was detected pathologically or radiologically.

Results: The median of follow-up was 22.6 months. RN was detected in 18.4% of the metastatic lesions, and 3.3% symptomatic, 15.1% asymptomatic. The median time of RN was 22.8 months (2.5-39.5), and the rates at 6, 12, and 24 months were 16.8%, 41.4%, and 66%, respectively. Univariate analysis revealed that Graded Prognostic Assessment (P = .005), Score Index of Radiosurgery (P = .015), Recursive Partitioning Analysis (P = .011), the presence of primary cancer (P = .004), and localization (P = .048) significantly increased the incidence of RN. No significant relationship between RN and brain-gross tumour volume doses, planning target volume, fractionation, dose (P > .05). Multivariate analysis identified SIR > 6 (OR: 1.30, P = .021), primary of breast tumour (OR: 2.33, P = .031) and supratentorial localization (OR: 3.64, P = .025) as risk factors.

Conclusions: SRT is used effectively in BMs. The incidence of RN following SRT is undeniably frequent. It was observed that the incidence rate increased as the follow-up period increased. We showed that brain-GTV doses are not predictive of RN development, unlike other publications. In study, a high SIR score and supratentorial localization were identified as factors that increased the risk of RN.

Advances in knowledge: RN is still a common complication after SRT. Symptomatic RN is a significant cause of morbidity. The causes of RN are still not clearly identified. In many publications, brain dose and volumes have been found to be effective in RN. But, with this study, we found that brain dose volumes and fractionation did not increase the incidence of RN when brain doses were taken into account. The most important factor in the development of RN was found to be related to long survival after SRT.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
对接受立体定向放射治疗的脑转移患者发生放射性坏死的风险因素进行调查。
目的研究接受立体定向放射治疗(SRT)的脑转移瘤放射性坏死(RN)的发生率、发生时间和预测因素:研究评估了2010年至2020年期间专门接受SRT治疗的245例脑转移瘤。结果:随访时间的中位数为 22.5 年:中位随访时间为 22.6 个月。18.4%的转移病灶中检测到RN,3.3%有症状,15.1%无症状。RN的中位时间为22.8个月(2.5-39.5),6、12和24个月时的比率分别为16.8%、41.4%和66%。单变量分析显示,分级预后评估(p = 0.005)、放射外科评分指数(p = 0.015)、递归分区分析(p = 0.011)、原发癌的存在(p = 0.004)和定位(p = 0.048)会显著增加 RN 的发生率。RN与脑总肿瘤体积剂量、计划目标体积、分层、剂量之间无明显关系(p > 0.05)。多变量分析发现,SIR > 6(OR:1.30,p = 0.021)、乳腺肿瘤原发(OR:2.33,p = 0.031)和幕上定位(OR:3.64,p = 0.025)是风险因素:结论:SRT可有效用于乳腺肿瘤。不可否认,SRT 后 RN 的发生率很高。据观察,随着随访时间的延长,发病率也在增加。我们的研究表明,与其他出版物不同的是,脑 GTV 剂量并不能预测 RN 的发生。在研究中,SIR评分高和脑室上定位被认为是增加放射性坏死风险的因素:放射性坏死仍是 SRT 后常见的并发症。无症状放射性坏死是发病的重要原因。放射性坏死的原因仍未明确。在许多出版物中,脑剂量和脑容量被认为对 RN 有效。但在这项研究中,我们发现如果将脑部剂量考虑在内,脑部剂量体积和分次并不会增加 RN 的发生率。研究发现,RN发生的最重要因素与SRT后的长期存活率有关。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
British Journal of Radiology
British Journal of Radiology 医学-核医学
CiteScore
5.30
自引率
3.80%
发文量
330
审稿时长
2-4 weeks
期刊介绍: BJR is the international research journal of the British Institute of Radiology and is the oldest scientific journal in the field of radiology and related sciences. Dating back to 1896, BJR’s history is radiology’s history, and the journal has featured some landmark papers such as the first description of Computed Tomography "Computerized transverse axial tomography" by Godfrey Hounsfield in 1973. A valuable historical resource, the complete BJR archive has been digitized from 1896. Quick Facts: - 2015 Impact Factor – 1.840 - Receipt to first decision – average of 6 weeks - Acceptance to online publication – average of 3 weeks - ISSN: 0007-1285 - eISSN: 1748-880X Open Access option
期刊最新文献
Calculating Optic Nerve Planning Organ at Risk Volume Margins for Stereotactic Radiosurgery Using Optic Nerve Motion determined using MRI. Paediatric magnetoencephalography and its role in neurodevelopmental disorders. Role of contrast-enhanced mammogram as an adjunct to tomosynthesis in evaluation of circumscribed breast lesions. Acceptance and results of cryoablation for the treatment of early breast cancer in non-surgical patients. Preoperative imaging of colorectal liver metastases: what the radiologist and the multidisciplinary team need to know.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1